Computed Tomography Coronary Angiography Before Stent Implantation

This study has been completed.
Sponsor:
Collaborator:
Ministerstwo Nauki i Szkolnictwa Wyższego, Warszawa, Polska
Information provided by:
Institute of Cardiology, Warsaw, Poland
ClinicalTrials.gov Identifier:
NCT01205425
First received: June 25, 2010
Last updated: July 4, 2011
Last verified: July 2011

June 25, 2010
July 4, 2011
September 2009
April 2011   (final data collection date for primary outcome measure)
  • Minimal in stent lumen area as assessed by IVUS [ Time Frame: Up to 10 minutes after stent implantation ] [ Designated as safety issue: No ]
  • Adequacy of lesion coverage defined as minimal lumen area in reference segments adjacent to stent shoulder. [ Time Frame: Up to 10 minutes after stent implantation ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01205425 on ClinicalTrials.gov Archive Site
  • Mean stent lumen area [ Time Frame: Up to 10 minutes after stent implantation ] [ Designated as safety issue: No ]
  • Mean lumen area and plaque and media area in 10mm segments adjucent to stent edges. [ Time Frame: Up to 10 minutes after stent implantation ] [ Designated as safety issue: No ]
  • Qualitative and quantitative assessment of potential complications (tissue prolaps, plaque shift, stent edge dissection and stent malapossition) [ Time Frame: Up to 10 minutes after stent implantation ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Computed Tomography Coronary Angiography Before Stent Implantation
Role of Computed Tomography Coronary Angiography in Optimalization of Percutaneous Coronary Interventions With Stent Implantation.

The purpose of the study is to determine whether results of the computed tomography coronary angiography may be helpful in planning and performing percutaneous angioplasty in patients with stable angina pectoris.

Currently most percutaneous coronary interventions (PCI) are planned and performed on the basis of invasive coronary angiography which provides the information that is confined to the vessel lumen. This limitation may be partially responsible for the unfavorable long term outcome and complications that occur in some patients. Additional information on the disease burden in angiographically normal coronary segments adjacent to the lesion site could impact the treatment strategy and clinical results. Imaging modalities that allow not only lumen but also vessel wall assessment include both invasive (e.g. intravascular ultrasounds - IVUS) and non-invasive (e.g. multislice computed tomography - MSCT) methods. IVUS guidance of the coronary interventions is expensive and given its invasiveness is related to the additional risk. The number of patients who are referred for coronary angiography with significant stenosis diagnosed with MSCT is rapidly increasing. Most interventional cardiologists are not familiar with coronary vessel images produced by MSCT. The aim of our study is to assess if the analyses of MSCT images before the PCI may impact the treatment strategy and immediate results. The study will enroll subjects with significant coronary stenosis diagnosed with MSCT who are referred to the catheterisation laboratory for invasive angiography and PCI. The study participants will be randomized into two groups:

Group 1 - the results of MSCT are analysed by the interventional cardiologist that is to perform angiography and PCI. Based on this analysis preliminary procedural strategy is planned (stent diameters, decision on direct stenting vs. predilatation, decision on postdilation) Group 2 - interventional cardiologist is blinded to the images obtained by MSCT. The PCI procedure is performed solely on the basis of invasive coronary angiography In both study groups IVUS will be performed before and after stent implantation. The operator will be blinded to the results of pre-PCI IVUS. The second IVUS will be performed when angiographic results are optimal in the opinion of the operator. The results of the second IVUS examination will be the efficacy measure of the two compared treatment strategies.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Diagnostic
Stable Coronary Artery Disease
  • Other: PCI on the basis of coronary angiography
    Interventional cardiologist will be blinded to the images obtained by CT. The PCI procedure will be planned and performed solely on the basis of invasive coronary angiography
  • Procedure: CT guided PCI
    The results of the CT scan will be analysed by the interventional cardiologist that is to perform angiography and PCI. Based on this analysis preliminary procedural strategy is planned (stent diameters, decision on direct stenting vs. predilatation, decision on postdilation)
  • Experimental: CT
    Procedure of stent implantation will be planed on the basis of both angiography and computed tomography results.
    Intervention: Procedure: CT guided PCI
  • Active Comparator: Angio
    Procedure of stent implantation will be planned only on the basis of diagnostic coronary angiography.
    Intervention: Other: PCI on the basis of coronary angiography
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
June 2011
April 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Stable coronary artery disease
  • Planned stent implantation into single lesion in native coronary artery
  • Planned stent diameter: 2.5-4.0 mm

Exclusion Criteria:

  • Women younger than 50 years
  • Lesion location in left main coronary artery
  • Atrial fibrilation or other significant arrythmia
  • Severe chronic obturatory pulmonary disease
  • Hyperthyroidism
  • Known allergy to contrast media
  • Glomerular filtration rate < 30
  • Treatment of bifurcation lesion
  • Stent implantation for in-stent restenosis
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Poland
 
NCT01205425
N N403 295736
No
Jerzy Pregowski, Institute of Cardiology, 04-628 Warsaw, Poland
Institute of Cardiology, Warsaw, Poland
Ministerstwo Nauki i Szkolnictwa Wyższego, Warszawa, Polska
Principal Investigator: Jerzy Pregowski, MD Institute of Cardiology, Warsaw, Poland
Institute of Cardiology, Warsaw, Poland
July 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP